Zeinali Sirous, Davoudi-Dehaghani Elham, Azadmehr Sarah, DabbaghBagheri Samira, Bagherian Hamideh, Jamali Mojdeh, Zafarghandimotlagh Fatemeh, Masoodifard Mahboobeh, BandehiSarhaddi Ameneh, Rejali Leili, Sahebi Sepideh
Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Pasteur St., Tehran, Iran,
Eur Arch Otorhinolaryngol. 2015 Sep;272(9):2255-9. doi: 10.1007/s00405-014-3171-7. Epub 2014 Jul 11.
GJB2 mutation analysis is used routinely as a first step in genetic testing for autosomal recessive non-syndromic sensorineural hearing loss. Although most GJB2 mutations can be detected by sequencing of the exon 2 of this gene, a prevalent splice mutation, c.-23+1G>A (IVS1+1G>A), is not usually included in the analyzed region. In this study, we have developed an ARMS-PCR strategy for detection of this mutation among Iranian deaf individuals. A total of 418 Iranian individuals with hearing loss consistent with autosomal recessive non-syndromic sensorineural hearing loss based on audiological test result, medical history, physical examination and pedigree of the family, were included in this study. c.35delG and c.-23+1G>A mutations were detected by using ARMS-PCR. Direct sequencing of the exon 2 of the GJB2 gene was performed for mutation analysis of the coding region of this gene. Among 418 investigated cases, a total of 81 patients (~19.4 %) with biallelic pathogenic mutations in the GJB2 gene and 13 cases with only one pathogenic mutant allele were identified. The total allele frequencies of the two most frequent mutations, c.35delG and c.-23+1G>A, among mutated alleles were found to be around 59 and 15.7 %, respectively. High frequency of the c.35delG and c.-23+1G>A mutations among Iranian deaf individuals shows the importance of developing rapid and cost-effective methods for primary mutation screening methods before performing direct sequencing.
GJB2突变分析通常被用作常染色体隐性非综合征性感音神经性听力损失基因检测的第一步。尽管该基因外显子2的测序可检测到大多数GJB2突变,但一种常见的剪接突变c.-23+1G>A(IVS1+1G>A)通常不包括在分析区域内。在本研究中,我们开发了一种ARMS-PCR策略,用于在伊朗聋人个体中检测该突变。基于听力学测试结果、病史、体格检查和家族谱系,共有418名符合常染色体隐性非综合征性感音神经性听力损失的伊朗听力损失个体纳入本研究。采用ARMS-PCR检测c.35delG和c.-23+1G>A突变。对GJB2基因外显子2进行直接测序,以分析该基因编码区的突变。在418例受调查病例中,共鉴定出81例(约19.4%)GJB2基因双等位基因致病性突变患者和13例仅携带一个致病性突变等位基因的病例。在突变等位基因中,两个最常见突变c.35delG和c.-23+1G>A的总等位基因频率分别约为59%和15.7%。伊朗聋人个体中c.35delG和c.-23+1G>A突变的高频率表明,在进行直接测序之前,开发快速且经济高效的一级突变筛查方法非常重要。